Protecting Medicare from Excessive Price Increases Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 1, 2018)
Protecting Medicare from Excessive Price Increases Act of 2018
This bill requires a drug manufacturer to pay a Medicare rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.
What just happenedMar 9, 2018
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 1, 2018
- Mar 9, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 2, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 1, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Mar 1, 2018IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Mar 1, 2018IntroReferralIntro-H
Introduced in House
- Mar 1, 2018IntroReferral1000
Introduced in House